MetaCap

Opus Genetics Insider Trades

NASDAQ: IRDHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.65+0.19 (+4.26%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
17 · $10.75M
Shares bought / sold
0 / 2.39M
Net activity
Net selling $10.7 million

Opus Genetics insider activity

Over the last 12 months, Opus Genetics insiders reported 41 transactions on SEC Form 4: 0 open-market purchases and 17 sales. Insiders bought $0 and sold $10.7 million worth of stock, for net insider selling of $10.7 million. The largest seller was Foundation Fighting Blindness Retinal Degeneration Fund & Foundation Fighting Blindness, Inc., with $10.2 million in reported sales.

The most recent filing shows Foundation Fighting Blindness Retinal Degeneration Fund & Foundation Fighting Blindness, Inc. (Director) selling 556,000 shares at $4.96 on Sep 30, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put IRD's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

IRD insider transactions

Opus Genetics insider transactions
DateInsiderTypeSharesValueFiling
Sep 30, 2026Foundation Fighting Blindness Retinal Degeneration Fund & Foundation Fighting Blindness, Inc.DirectorSale556,000$2.76MForm 4
Sep 9, 2026Magrath GeorgeChief Executive OfficerTax withholding75,541$450.98KForm 4
Sep 9, 2026Magrath GeorgeChief Executive OfficerOption exercise392,157$450.98KForm 4
Sep 8, 2026Gallagher CamDirectorOption exercise784,314$901.96KForm 4
Sep 3, 2026Gagnon Robert E.Chief Financial OfficerSale28,000$127.21KForm 4
Jul 23, 2026Gagnon Robert E.Chief Financial OfficerSale7,783$22.94KForm 4
Jul 23, 2026Magrath GeorgeChief Executive OfficerSale9,475$27.93KForm 4
Jul 23, 2026SCHACHLE JOSEPH KChief Operating OfficerSale4,644$13.65KForm 4
Jul 23, 2026YERXA BENJAMIN RPresidentSale7,429$22.06KForm 4
May 18, 2026Foundation Fighting Blindness Retinal Degeneration Fund & Foundation Fighting Blindness, Inc.DirectorSale1,700,000$7.39MForm 4
Apr 23, 2026Gagnon Robert E.Chief Financial OfficerSale7,842$40.66KForm 4
Apr 23, 2026Jayagopal AshwathChief Scientific & Dev. Ofc.Sale7,542$39.16KForm 4
Apr 23, 2026Magrath GeorgeChief Executive OfficerSale9,511$49.65KForm 4
Apr 23, 2026Zaremba Rabourn AmyHead of Fin. Quality AssuranceSale1,641$8.54KForm 4
Apr 23, 2026YERXA BENJAMIN RPresidentSale7,470$39.12KForm 4
Apr 23, 2026SCHACHLE JOSEPH KChief Operating OfficerSale4,697$24.52KForm 4
Apr 20, 2026Bennett JeanDirectorAward24,367—Form 4
Apr 20, 2026Benton SusanDirectorAward24,367—Form 4
Apr 20, 2026Gallagher CamDirectorAward24,367—Form 4
Apr 20, 2026Ainsworth SeanDirectorAward24,367—Form 4
Apr 20, 2026MANUSO JAMES S JDirectorAward24,367—Form 4
Apr 20, 2026Rodgers Richard JDirectorAward24,367—Form 4
Apr 20, 2026Graves Adrienne LDirectorAward24,367—Form 4
Mar 16, 2026Jayagopal AshwathChief Scientific & Dev. Ofc.Sale3,719$19.05KForm 4
Mar 16, 2026SCHACHLE JOSEPH KChief Operating OfficerSale3,719$19.53KForm 4
Mar 16, 2026Magrath GeorgeChief Executive OfficerSale24,438$127.33KForm 4
Mar 16, 2026Zaremba Rabourn AmyHead of Fin. Quality AssuranceSale2,816$14.77KForm 4
Feb 12, 2026Jayagopal AshwathChief Scientific & Dev. Ofc.Tax withholding5,313$18.01KForm 4
Jan 22, 2026Jayagopal AshwathChief Scientific & Dev. Ofc.Award400,000—Form 4
Jan 22, 2026Magrath GeorgeChief Executive OfficerAward483,639—Form 4
Jan 22, 2026Zaremba Rabourn AmyHead of Fin. Quality AssuranceAward86,500—Form 4
Jan 22, 2026Gagnon Robert E.Chief Financial OfficerAward400,000—Form 4
Jan 22, 2026SCHACHLE JOSEPH KChief Operating OfficerAward250,000—Form 4
Jan 22, 2026YERXA BENJAMIN RPresidentAward400,000—Form 4
Jan 18, 2026Zaremba Rabourn AmyHead of Fin. Quality AssuranceTax withholding3,390$7.12KForm 4
Jan 10, 2026Zaremba Rabourn AmyHead of Fin. Quality AssuranceTax withholding3,950$7.62KForm 4
Jan 6, 2026Gallagher CamDirectorAward67,000—Form 4
Jan 1, 2026Graves Adrienne LDirectorAward23,643—Form 4
Jan 1, 2026Ainsworth SeanDirectorAward42,507—Form 4
Jan 1, 2026MANUSO JAMES S JDirectorAward31,188—Form 4
Jan 1, 2026Bennett JeanDirectorAward21,127—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related